Navigation Links
ZONARE Surpasses 1000th Worldwide Ultrasound System Shipment

Developer of Zone Sonography(TM) Technology to Install Milestone Unit at

the German Cancer Research Center

CHICAGO, Nov. 26 /PRNewswire/ -- ZONARE Medical Systems, a developer of premium ultrasound systems, announced at the Radiology Society of North America (RSNA) Annual Congress, being held November 25 - 30, 2007, it has recently shipped the company's 1,000th Convertible Ultrasound(TM) platform to the German Cancer Research Center. The Center is one of the most respected cancer research facilities in Europe. Researchers believe ZONARE's proprietary Zone Sonography(TM) technology will provide significant value in their ongoing research activities.

"Our work mainly involves functional examinations, particularly contrast-enhanced ultrasound and quantification of blood flow," said Professor Stefan Delorme from the Radiology Department of the German Cancer Research Center. "In order to be able to perform certain types of scientific evaluations, we require data that extends far beyond the information that video or DICOM sources are capable of providing to us. ZONARE has really convinced us with its Zone Sonography technology and we are certain that this system will be of great value to us in our everyday work."

Zone Sonography technology has enabled ZONARE Medical Systems to bring its unique, patented Convertible Ultrasound platform to the industry providing premium image quality and performance together with greater portability at an attractive price to value ratio compared to other ultrasound systems. Clinicians are able to convert the system from a full-featured, cart-based system into a premium compact ultrasound system at the touch of a button, optimizing its versatility in a variety of clinical settings, without sacrificing image quality or performance.

Zone Sonography technology has also provided the basis for many other clinical imaging advancements such as Auto-Opt with ZST. Auto-Opt with ZST automatically adjusts sound speed based on differences in a patient's body habitus while completely optimizing the clinical image and instantly equalizing image gain and brightness.

"ZONARE is prepared to work with us at a very challenging scientific level," said Professor Delorme. "We were very much convinced of the value of this system immediately after it was presented to us. Due to Zone Sonography technology, we have the ability to modify the speed at which ultrasound reflects off of tissue on a customized basis. This enables us to assess the size of structures more reliably on the one hand, yet achieve much higher image quality. Although this is of great benefit to all types of diagnostics, it is especially beneficial in diagnosing cancer."

The system's Zone Sonography software-based architecture allows its performance to continue to improve as greater processing power becomes available. System upgrades can be downloaded via the internet, allowing for fast, convenient advances in clinical capabilities, enabling clinicians to cost-effectively maintain a state of the art premium ultrasound system.

Based in Heidelberg, Germany, The German Cancer Research Center is a member of the Helmholtz Association, the largest scientific organization in Germany. This is the first system installation for this renowned research center.

"As the sales and shipments of our unique, patented Convertible Ultrasound platform have continued to increase, we have been privileged to become a partner with hundreds of healthcare providers around the world," said Donald Southard, president and CEO for ZONARE. "We believe our mutual goal to provide excellence in patient care will extend these partnerships well into the future. With Zone Sonography technology as the basis, we look forward to developing new advances in ultrasound, bringing both clinical and economic value to our customers."

About the German Cancer Research Center

The German Cancer Research Center is a foundation under public law and a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren). As a national research center it is financed by the Federal German Government and the State of Baden-Wuerttemberg. The goal of the Center is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to be developed into new approaches in the prevention, diagnosis, and treatment of cancer. For further information, visit

About ZONARE Medical Systems

ZONARE Medical Systems, Inc., is a privately-held company that designs, develops, and manufactures premium performance compact ultrasound solutions, which combine its proprietary technology with an innovative physical design. Zone Sonography technology, ZONARE's unique patented approach to ultrasound imaging, is focused on bringing premium image quality and performance to clinical settings, leading to advanced diagnostic capabilities, portability, cost-effective operation, maintenance and upgrades, and attractive value to clinicians. For more information, please visit our web site at

SOURCE ZONARE Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. ZONARE Names Marcotte Chief Financial Officer
2. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
3. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
4. Global Med Technologies(R) Extends Its Worldwide Outreach
5. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
6. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
7. New USAID grant helps Georgetown meet unmet family planning needs worldwide
8. The Cardiovascular Multimedia Network (CVMD) and the International Society of Endovascular Specialists (ISES) Join Forces to Educate Practitioners Worldwide Through Electronic Media
9. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
10. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
11. Allscripts Featured in Microsoft HealthVault Worldwide Launch
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Florida Hospital Tampa is the first health care provider ... state of Florida. , vBloc® Therapy is a vagal blocking therapy, delivered via the Maestro® ... body mass index (BMI) of at least 40 to 45 kg, or a BMI of ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one ... Surgery, has been named by MedEsthetics magazine as the Best Single Physician Practice in ... among the many elite aesthetic physicians honored by the industry publication. , Dr. ...
(Date:12/1/2015)... Delaware (PRWEB) , ... December 01, 2015 , ... ... winner at the 7th Annual 2015 Golden Bridge Business Awards under the New ... is a zero capex web based sample management software that helps ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- Six months of adjunctive metformin therapy does not improve glycemic ... new research from T1D Exchange and funded by ... effect on measures of obesity, including weight and BMI. The ... of the American Medical Association , are from the largest ... overweight and obese adolescents with type 1 diabetes. ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... 1, 2015 Contraceptives ... Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, ... Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) ... Trends and Forecast 2014 - 2020 ", ... (TMR).The report states that the global contraceptives ...
Breaking Medicine Technology: